HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

USDA under secretary nominee

This article was originally published in The Tan Sheet

Executive Summary

The Obama administration nominates Kevin Concannon as Department of Agriculture under secretary for food, nutrition and consumer cervices. If confirmed, Concannon will serve with Secretary Tom Vilsack and replace acting Under Secretary Beth Johnson (1"The Tan Sheet" Sept. 29, 2008, p. 14). Concannon served as director of the Iowa Department of Human Services from 2003 to 2008, according to an April 17 release. He also was director of health and human services agencies in Maine and Oregon

You may also be interested in...



Concannon confirmed for USDA post

The Senate confirms Kevin Concannon as under secretary of agriculture for food, nutrition and consumer services July 31. Concannon previously led health and human services departments in Iowa, Maine and Oregon (1"The Tan Sheet" May 4, 2009, In Brief)

People In Brief

Zerhouni leaving NIH: National Institutes of Health Director Elias Zerhouni will leave his post at the end of October to pursue other opportunities, according to a Sept. 24 letter to NIH staff. He says he is "extremely fortunate to have led the agency that has been at the center of" a biomedical science revolution, "one that continues to have broad and profound implications for human health." Zerhouni says he will work with Health and Human Services Secretary Mike Leavitt to appoint his successor at NIH. A same-day NIH release details Zerhouni's achievements since his confirmation as director in 2002, including establishing ethics regulations to address outside consulting by NIH employees and starting public health research initiatives, such as the NIH Obesity Research Task Force (1"The Tan Sheet" May 6, 2002, In Brief and 2"The Tan Sheet" Aug. 29, 2005, p. 11)

Roche Continues To Make The Case For Gantenerumab In Alzheimer’s Disease

The amyloid-targeting drug is years behind Biogen/Eisai’s aducanumab, but its subcutaneous administration and the GRADUATE studies’ design could give Roche’s gantenerumab an advantage.

Topics

UsernamePublicRestriction

Register

RS135709

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel